Histotripsy of blood clots within a hollow cylindrical transducer for aspiration thrombectomy applications
Li Gong, Alex R. Wright, Kullervo Hynynen, and David E. Goertz

TL;DR
This study demonstrates that histotripsy can effectively degrade blood clots within a hollow cylindrical transducer, potentially improving aspiration thrombectomy procedures by making clot removal more successful.
Contribution
It introduces a novel application of histotripsy within a hollow cylindrical transducer to enhance clot degradation during aspiration thrombectomy.
Findings
Lesions form rapidly within 0.1 seconds along the transducer axis.
Larger lesion volumes are achieved with shorter pulse lengths and higher PRF.
Feasibility of degrading clots within cylindrical transducers is confirmed.
Abstract
Thrombolytic occlusions in stroke, pulmonary embolism and the peripheral vasculature are increasingly treated with aspiration, a catheter-based approach that employs suction to extract clots through a hollow catheter lumen. Unfortunately, aspiration is frequently unsuccessful in extracting more challenging clots, which can become corked in the distal tip. We hypothesize that clot extraction can be enhanced by using histotripsy to degrade the mechanical integrity of clot material within the lumen of a hollow cylindrical transducer which can be situated at the tip of an aspiration catheter. To demonstrate the feasibility of degrading clot material within the lumen of a hollow cylindrical transducer, the effect of pulsing schemes on lesion generation within clots was assessed using a retracted clot model. A radially polarized cylindrical transducer (2.5 mm and 3.3 mm for inner and outer…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAcute Ischemic Stroke Management · Gastric Cancer Management and Outcomes · Angiogenesis and VEGF in Cancer
